Category: Biomarker [@airaksinen2002]
Target: GDNF protein [@kordower2000]
Sample Type: Blood (plasma/serum), CSF [@saarma2006]
Diseases: Parkinson's Disease, ALS, Huntington's Disease, Spinal Cord Injury, Peripheral Neuropathy [@nightingale2004]
Direction: Decreased in neurodegeneration; therapeutic potential [@ramadan2020]
Sensitivity: pg/mL range in blood [@bartus2011]
Overview
Glial Cell Line-Derived Neurotrophic Factor (GDNF) is a potent neurotrophin that promotes the survival and function of dopaminergic neurons and motor neurons. GDNF was initially discovered for its ability to promote the survival of ventral midbrain dopaminergic neurons, making it a particularly promising therapeutic candidate for Parkinson's disease. It also supports motor neuron survival, with applications in ALS and spinal cord injury. [@sullivan2016]
Category: Biomarker [@airaksinen2002]
Target: GDNF protein [@kordower2000]
Sample Type: Blood (plasma/serum), CSF [@saarma2006]
Diseases: Parkinson's Disease, ALS, Huntington's Disease, Spinal Cord Injury, Peripheral Neuropathy [@nightingale2004]
Direction: Decreased in neurodegeneration; therapeutic potential [@ramadan2020]
Sensitivity: pg/mL range in blood [@bartus2011]
Overview
Glial Cell Line-Derived Neurotrophic Factor (GDNF) is a potent neurotrophin that promotes the survival and function of dopaminergic neurons and motor neurons. GDNF was initially discovered for its ability to promote the survival of ventral midbrain dopaminergic neurons, making it a particularly promising therapeutic candidate for Parkinson's disease. It also supports motor neuron survival, with applications in ALS and spinal cord injury. [@sullivan2016]
GDNF represents a promising neurotrophic factor biomarker for neurodegenerative diseases, particularly Parkinson's disease. While challenges remain regarding CNS penetration and receptor dependency, ongoing gene therapy trials and biomarker combination approaches offer hope for clinical utility. Monitoring GDNF levels alongside other disease markers may provide valuable insights into disease progression and treatment response.
Background
The study of Gdnf Neurotrophic Factor Biomarker has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.